Affiliation:
1. Department of Infectious Diseases, Danderyd Hospital, Sweden.
Abstract
An enzyme-linked immunosorbent assay (ELISA) for the immunoglobulin G (IgG), IgM, and IgA response to Bordetella pertussis filamentous hemagglutinin (FHA) and pertussis toxin (PT) and a neutralization test (NT) in a microplate tissue culture assay for neutralizing antibodies to PT were evaluated in paired sera from 90 patients with culture-confirmed pertussis. Eighty patients were children (age, less than 15 years), and 6 of 80 children had been immunized with three doses of diphtheria-tetanus-pertussis vaccine as infants. A significant titer rise (greater than or equal to twofold), determined by ELISA, of IgG, IgM, and IgA to FHA was recorded in 75 (83%), 28 (31%), and 47 (52%) of the patients, respectively. A significant titer rise to PT in IgG was found in 83 (92%), IgM in 29 (32%), and IgA in 44 (49%) of the patients. A significant titer rise to FHA or PT in IgG was found in 88 (98%) of the patients, in combination with a significant rise in the titer of IgA to FHA. These data were obtained in a single serum dilution of 1:500. Titrations performed later showed that the titer rise to FHA in IgG was a mean of 6.5-fold, which was significantly lower than the mean 67.0-fold rise in IgG to PT (P less than 0.001). The mean titer of IgG to FHA in convalescent-phase serum was 270, which was also significantly lower than the mean PT titer of 2,943 (P less than 0.001). A significant rise (greater than or equal to fourfold) in PT titer by NT was found in 58 of 83 (70%) of the patients. The NT was significantly less sensitive than the ELISA for the determination of the IgG titer to PT ( P< 0.001). Results showed that a 100% (90 of 90) sensitivity in terms of titer rises was achieved in the serologic diagnosis of pertussis by ELISA in a single-point determination of the IgG and IgA responses to FHA and of the IgG response to PT.
Publisher
American Society for Microbiology
Reference20 articles.
1. Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay;Askelof P.;J. Med. Microbiol.,1982
2. Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6;Blennow M.;Dev. Biol. Stand.,1986
3. Serological response to filamentous hemagglutinin and Iymphocytosis-promoting toxin of Bordetella pertussis;Burstyn D. G.;Infect. Immun.,1983
4. The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity;Butler J. E.;Immunochemistry,1978
5. Cowell J. L. Y. Sato H. Sato B. An der Lan and C. R. Manclark. 1982. Separation purification and properties of the filamentous hemagglutinin and the leukocytosis promoting factor-hemagglutinin from Bordetella pertussis p. 371-379. In J. B. Robbins J. C. Hill and C. Sadoff (ed.) Seminars in infectious disease vol. 9. Pertussis components. Thieme-Stratton New York.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献